Author - Sequoia Direct

OncoSil Medical (ASX:OSL) gets CE approval

01 Jun 2020 - OncoSil Medical Limited (ASX:OSL) Managing Director and CEO Daniel Kenny talks about the significance of the company's CE Marking approval for its lead product OncoSil, which helps treat pancreatic, liver and biliary duct cancer.

Read more...

5th consecutive week of gains: Aus gain 4.5% over week

29 May 2020 - Despite today’s losses, the market finished the week 4.5% higher. That’s the fifth consecutive week of gains for the ASX200. Investors are optimistic that the easing of covid-19 restrictions will signal an economic rebound. Heavy industry engineering and construction company Lycopodium (ASX:LYL) has revised its NPAT guidance for the financial year ending 30 June down to $11.5 million.

Read more...